These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23908349)

  • 1. Restriction of calpain3 expression to the skeletal muscle prevents cardiac toxicity and corrects pathology in a murine model of limb-girdle muscular dystrophy.
    Roudaut C; Le Roy F; Suel L; Poupiot J; Charton K; Bartoli M; Richard I
    Circulation; 2013 Sep; 128(10):1094-104. PubMed ID: 23908349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A.
    Bartoli M; Roudaut C; Martin S; Fougerousse F; Suel L; Poupiot J; Gicquel E; Noulet F; Danos O; Richard I
    Mol Ther; 2006 Feb; 13(2):250-9. PubMed ID: 16290124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limb-girdle muscular dystrophy 2A.
    Gallardo E; Saenz A; Illa I
    Handb Clin Neurol; 2011; 101():97-110. PubMed ID: 21496626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A.
    Lostal W; Roudaut C; Faivre M; Charton K; Suel L; Bourg N; Best H; Smith JE; Gohlke J; Corre G; Li X; Elbeck Z; Knöll R; Deschamps JY; Granzier H; Richard I
    Sci Transl Med; 2019 Nov; 11(520):. PubMed ID: 31776291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome.
    Chrobáková T; Hermanová M; Kroupová I; Vondrácek P; Maríková T; Mazanec R; Zámecník J; Stanek J; Havlová M; Fajkusová L
    Neuromuscul Disord; 2004 Oct; 14(10):659-65. PubMed ID: 15351423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAPN3-mediated processing of C-terminal titin replaced by pathological cleavage in titinopathy.
    Charton K; Sarparanta J; Vihola A; Milic A; Jonson PH; Suel L; Luque H; Boumela I; Richard I; Udd B
    Hum Mol Genet; 2015 Jul; 24(13):3718-31. PubMed ID: 25877298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated Ca(2+) release in a mouse model of limb girdle muscular dystrophy 2A.
    DiFranco M; Kramerova I; Vergara JL; Spencer MJ
    Skelet Muscle; 2016; 6():11. PubMed ID: 26913171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of limb girdle muscular dystrophy type 2a in 6 Iranian patients, one with a novel deletion in CAPN3 gene.
    Fadaee M; Kariminejad A; Fattahi Z; Nafissi S; Godarzi HR; Beheshtian M; Vazehan R; Akbari MR; Kahrizi K; Najmabadi H
    Neuromuscul Disord; 2016; 26(4-5):277-82. PubMed ID: 27020652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to up-regulate transcription of genes necessary for muscle adaptation underlies limb girdle muscular dystrophy 2A (calpainopathy).
    Kramerova I; Ermolova N; Eskin A; Hevener A; Quehenberger O; Armando AM; Haller R; Romain N; Nelson SF; Spencer MJ
    Hum Mol Genet; 2016 Jun; 25(11):2194-2207. PubMed ID: 27005420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.
    Rodino-Klapac LR; Lee JS; Mulligan RC; Clark KR; Mendell JR
    Neurology; 2008 Jul; 71(4):240-7. PubMed ID: 18525034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired regeneration in calpain-3 null muscle is associated with perturbations in mTORC1 signaling and defective mitochondrial biogenesis.
    Yalvac ME; Amornvit J; Braganza C; Chen L; Hussain SA; Shontz KM; Montgomery CL; Flanigan KM; Lewis S; Sahenk Z
    Skelet Muscle; 2017 Dec; 7(1):27. PubMed ID: 29241457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle.
    Toral-Ojeda I; Aldanondo G; Lasa-Elgarresta J; Lasa-Fernández H; Fernández-Torrón R; López de Munain A; Vallejo-Illarramendi A
    Expert Rev Mol Med; 2016 Apr; 18():e7. PubMed ID: 27055500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autolytic activation of calpain 3 proteinase is facilitated by calmodulin protein.
    Ermolova N; Kramerova I; Spencer MJ
    J Biol Chem; 2015 Jan; 290(2):996-1004. PubMed ID: 25389288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy.
    Vissing J; Barresi R; Witting N; Van Ghelue M; Gammelgaard L; Bindoff LA; Straub V; Lochmüller H; Hudson J; Wahl CM; Arnardottir S; Dahlbom K; Jonsrud C; Duno M
    Brain; 2016 Aug; 139(Pt 8):2154-63. PubMed ID: 27259757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epilepsy and limb girdle muscular dystrophy type 2A: double trouble, serendipitous finding or new phenotype?
    Pizzanelli C; Mancuso M; Galli R; Choub A; Fanin M; Nascimbeni AC; Siciliano G; Murri L
    Neurol Sci; 2006 Jun; 27(2):134-6. PubMed ID: 16816913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer.
    Lostal W; Bartoli M; Bourg N; Roudaut C; Bentaïb A; Miyake K; Guerchet N; Fougerousse F; McNeil P; Richard I
    Hum Mol Genet; 2010 May; 19(10):1897-907. PubMed ID: 20154340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of calpains-1 and -2 prevents repair of plasma membrane scrape injuries, but not small pores, and induces a severe muscular dystrophy.
    Piper AK; Sophocleous RA; Ross SE; Evesson FJ; Saleh O; Bournazos A; Yasa J; Reed C; Woolger N; Sluyter R; Greer P; Biro M; Lemckert FA; Cooper ST
    Am J Physiol Cell Physiol; 2020 Jun; 318(6):C1226-C1237. PubMed ID: 32348180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in LAMA2 and CAPN3 genes associated with genetic and phenotypic heterogeneities within a single consanguineous family involving both congenital and progressive muscular dystrophies.
    Hadj Salem I; Kamoun F; Louhichi N; Rouis S; Mziou M; Fendri-Kriaa N; Makni-Ayadi F; Triki C; Fakhfakh F
    Biosci Rep; 2011 Apr; 31(2):125-35. PubMed ID: 20477750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limb-girdle muscular dystrophy type 2A can result from accelerated autoproteolytic inactivation of calpain 3.
    Garnham CP; Hanna RA; Chou JS; Low KE; Gourlay K; Campbell RL; Beckmann JS; Davies PL
    Biochemistry; 2009 Apr; 48(15):3457-67. PubMed ID: 19226146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappaB-dependent expression of the antiapoptotic factor c-FLIP is regulated by calpain 3, the protein involved in limb-girdle muscular dystrophy type 2A.
    Benayoun B; Baghdiguian S; Lajmanovich A; Bartoli M; Daniele N; Gicquel E; Bourg N; Raynaud F; Pasquier MA; Suel L; Lochmuller H; Lefranc G; Richard I
    FASEB J; 2008 May; 22(5):1521-9. PubMed ID: 18073330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.